PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
71 hedge funds and large institutions have $279M invested in Poseida Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 21 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
+9
Holders Change %
+14.52%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
15
Reduced
21
Closed
6
Calls
$3.42M
Puts
–
Net Calls
+$3.42M
Net Calls Change
+$3.29M
Top Buyers
| 1 |
JGC
1
J. Goldman & Co
New York
|
$2.03M |
| 2 |
2
Balyasny Asset Management
Chicago,
Illinois
|
$804K |
| 3 |
3
Northern Trust
Chicago,
Illinois
|
$2.46M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$5.15M |
| 5 |
PG
5
Pendal Group
Sydney,
Australia
|
$487K |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$10.5M |
| 2 |
2
BlackRock
New York
|
$25.5M |
| 3 |
SSA
3
Schonfeld Strategic Advisors
New York
|
$2.55M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$208K |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$20K |
